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Background
By studying hearts obtained from global BK-null mice
(BK-KO) in an ex vivo Langendorff perfusion setup we
and others previously found evidence for mitochondrial
BK channels (mitoBKs) in cardiomyocytes as infarct-
limiting factors [1,2]. It is well established that canonical
BK channels usually present at the plasma membrane of
cells are directly stimulated by the cyclic guanosine-
3’,5’-monophosphate (cGMP)/cGMP-dependent protein
kinase type I pathway; however, it is unclear whether
cardioprotection afforded by cardiomyocyte (CM) cGMP
in vivo requires mitoBK.
Methods
Using the Cre/loxP recombination system we generated
animals with a CM-restricted deletion of BK channels
(CMBK-KO) [3] and of nitric oxide (NO)-sensitive gua-
nylyl cyclases (CMsGC-KO) [4]. The susceptibility of
the conditional mutants to ischemia/reperfusion (I/R)
injury was compared to age- and litter-matched controls
(CMBK-CTR and CMsGC-CTR) as well as to global
BK-KO and BK wild-type (BK-WT) mice. An open
chest in situ model of myocardial infarction was applied
to determine differences in infarct size at baseline and
upon ischemic pre-/postconditioning (iPre/iPost) or
pharmacological interventions using either the BK
blocker paxilline, the BK opener NS11021 or the phos-
phodiesterase 5 (PDE5) inhibitors sildenafil and tadalafil,
which are cardioprotective agents that should signal via
increasing cGMP [5,6].
Results
Baseline infarct size of CMsGC-KOs did not differ from
that of CMsGC-CTRs, however, 30 min of ischemia fol-
lowed by 120 min of reperfusion provoked significantly
more cardiac damage in global BK-KO and CMBK-KO
mice than in age- and litter-matched BK-WTs and
CMBK-CTRs, respectively.
The BK blocker paxilline (applied 5 min after the onset
of ischemia) did not affect the response to I/R of CMBK-
KO hearts, whereas in hearts from CMBK-CTR mice we
observed an increase in the cardiac damage. With the BK
opener NS11021 (5 min before reperfusion) we observed
a more drastic decrease in the infarct size in hearts from
CMBK-CTR than in CMBK-KO mice.
As expected, short repetitive episodes of ischemia
applied directly after infarction (iPost) significantly
reduced the myocardial damage in all WT/CTR hearts,
whereas protection afforded by iPost was less pro-
nounced in the absence of mitoBK channels and comple-
tely abolished in hearts lacking CM NO-sGC.
Interestingly, cardioprotection elicited either by an
intra-atrial injection of sildenafil (5 min before reperfu-
sion) or by an i.p. injection of tadalafil (60 min before
the ischemic insult) also seems to require mitoBK and
NO-GC in the CM.
Conclusion
In summary, the presented findings demonstrate that
the lack of CM BK channels renders the heart more sus-
ceptible to I/R injury. Cardioprotection elicited by the
BK opener NS11021 suggests that BK channels may be
promising drug targets that interfere with the causes
and/or consequences of myocardial ischemia. Interest-
ingly, both CM NO-GC and BK are important to allow
the protective signaling events triggered either by short,
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repetitive episodes of ischemia or by agents targeting
PDE5. Further studies are needed to elucidate whether
cardioprotection via NO-GC and BK are linked by a
common cGMP pathway in the CM itself.
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